FourThought Financial Partners LLC lowered its stake in shares of Doximity, Inc. (NASDAQ:DOCS – Free Report) by 4.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 15,771 shares of the company’s stock after selling 794 shares during the quarter. FourThought Financial Partners LLC’s holdings in Doximity were worth $842,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors have also modified their holdings of the stock. Creative Planning boosted its stake in shares of Doximity by 13.7% during the third quarter. Creative Planning now owns 22,104 shares of the company’s stock worth $963,000 after buying an additional 2,671 shares during the period. Blue Trust Inc. grew its stake in Doximity by 107.2% in the 3rd quarter. Blue Trust Inc. now owns 2,870 shares of the company’s stock worth $125,000 after acquiring an additional 1,485 shares during the period. Allspring Global Investments Holdings LLC grew its stake in Doximity by 4.5% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 21,754 shares of the company’s stock worth $948,000 after acquiring an additional 934 shares during the period. State of Alaska Department of Revenue grew its stake in Doximity by 7.4% in the 3rd quarter. State of Alaska Department of Revenue now owns 14,240 shares of the company’s stock worth $620,000 after acquiring an additional 985 shares during the period. Finally, Smith Group Asset Management LLC grew its stake in Doximity by 38.8% in the 3rd quarter. Smith Group Asset Management LLC now owns 9,940 shares of the company’s stock worth $433,000 after acquiring an additional 2,780 shares during the period. Hedge funds and other institutional investors own 87.19% of the company’s stock.
Doximity Stock Performance
Shares of NASDAQ:DOCS opened at $71.86 on Wednesday. The company’s 50-day moving average is $60.96 and its 200 day moving average is $49.97. The company has a market capitalization of $13.42 billion, a P/E ratio of 71.86, a price-to-earnings-growth ratio of 4.10 and a beta of 1.39. Doximity, Inc. has a fifty-two week low of $22.96 and a fifty-two week high of $85.21.
Wall Street Analyst Weigh In
Check Out Our Latest Research Report on DOCS
Insider Activity at Doximity
In other news, Director Timothy S. Cabral sold 20,000 shares of the company’s stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the sale, the director now directly owns 6,360 shares in the company, valued at $366,463.20. This represents a 75.87 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 37.40% of the stock is currently owned by company insiders.
Doximity Company Profile
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Featured Articles
- Five stocks we like better than Doximity
- Bank Stocks – Best Bank Stocks to Invest In
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- Pros And Cons Of Monthly Dividend Stocks
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- The How and Why of Investing in Gold Stocks
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.